Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Times Interest Earned (2016 - 2026)

Aytu Biopharma has reported Times Interest Earned over the past 13 years, most recently at -$3.52 for Q4 2025.

  • Quarterly Times Interest Earned fell 123.94% to -$3.52 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.21 through Dec 2025, down 126.24% year-over-year, with the annual reading at -$2.11 for FY2025, 572.1% down from the prior year.
  • Times Interest Earned was -$3.52 for Q4 2025 at Aytu Biopharma, down from -$2.91 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $2.69 in Q1 2025 and troughed at -$10.44 in Q2 2025.
  • The 3-year median for Times Interest Earned is -$1.42 (2024), against an average of -$1.8.
  • The largest YoY upside for Times Interest Earned was 311.73% in 2025 against a maximum downside of 475.64% in 2025.
  • A 3-year view of Times Interest Earned shows it stood at $2.48 in 2023, then plummeted by 163.22% to -$1.57 in 2024, then tumbled by 123.94% to -$3.52 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Times Interest Earned are -$3.52 (Q4 2025), -$2.91 (Q3 2025), and -$10.44 (Q2 2025).